DATATRAK International's Web-based training module receives award for excellence

DATATRAK International, Inc. (Nasdaq: DATA) the leading and most experienced Application Service Provider (ASP) in the Electronic Data Capture (EDC) industry announced today that it was recently recognized by the Society for Technical Communication (STC) as a recipient of an "Award of Excellence" for its innovative Web-based training module developed for the Company's Version 2.2 of DATATRAK Entry(TM). DATATRAK Entry(TM) is the software application that physicians and research coordinators access via the Internet and use worldwide to enter clinical trial data in all therapeutic areas of research for the pharmaceutical industry. The training program, developed in partnership with MediaPro, Inc. of Bothell, WA, received this distinction in the Tutorials/Training category from the STC Puget Sound Chapter's 26th Annual Online Communication Competition. The DATATRAK Entry(TM) training module was one of 203 candidates, which showcased the work of over 600 authors and artists. STC is an individual membership organization made up of 25,000 experts who are dedicated to advancing the arts and sciences of technical communication -- the largest organization of its type in the world.

The Web-based training module for DATATRAK Entry(TM) allows investigators and coordinators to train remotely and independently from the comfort of their home or office via an intuitive, audio-enabled, auto-tutorial which automatically tracks user comprehension of the application. Web-based training is very cost-effective for sponsors of clinical research and is a critical component of the FDA guideline, 21 CFR, Part 11, since proper training is to be performed and documented for each user of electronic systems in the clinical trial process. Alternatives to Web-based training include physical, face-to-face meetings, which elevate sponsor costs and more-than- likely delay progress in clinical trial enrollment and completion. Moreover, turnover of personnel within a clinical trial is the norm and the ability to train an individual remotely and on command allows a clinical trial to advance uninterrupted from the EDC standpoint.

The Company is currently upgrading this Web-based training module to support the release of DATATRAK Entry(TM) Version 3.1, which is to be released in the spring of 2001.

"We are very honored to receive this award from STC," stated Dr. Jeffrey A. Green, President & CEO of DATATRAK International, Inc. "Training is a significant scalability and federally-regulated requirement of all EDC clinical trials and our ability to deploy and quantitatively characterize training remotely offers our customers significant timing and cost advantages over manual alternatives."

DATATRAK International, Inc. is a worldwide Application Service Provider for the electronic data capture industry. The Company provides a suite of EDC software products known as DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries. DATATRAK EDC(TM) was developed in order to deliver clinical research data from investigative sites to sponsors faster and more efficiently than conventional, manual methods. DATATRAK EDC(TM) can be deployed worldwide in either a distributed platform using laptop computers, in a centralized server environment with hardwire connections, or via wireless, handheld methodologies. All of these platforms use the Internet for data transmissions through an ASP delivery mode. DATATRAK EDC(TM) software and its earlier versions have successfully supported more than 50 clinical studies involving thousands of clinical research sites and encompassing greater than 28,000 patients in 31 countries. DATATRAK International, Inc. has offices located in Cleveland, Ohio and Bonn, Germany. Visit the DATATRAK International, Inc. Web site at www.datatraknet.com or www.datatraknet.de .

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. Factors that may cause actual results to differ materially from those in the forward- looking statements include the ability of the Company to absorb corporate overhead and other fixed costs in order to successfully market the DATATRAK EDC(TM) software; the development and fluctuations in the market for electronic data capture technology; continued unreliability of the Internet infrastructure; the degree of the Company's success in obtaining new contracts; the timing of payments from customers and the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; dependence on key personnel; governmental regulation; the early stage of the Company's EDC business and operations; and general economic conditions. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry.

SOURCE DATATRAK International, Inc.